Board of Directors
CHOOSE THE GOLDEN
LIFE SCIENCES BREAKTHROUGHS
Our expert team is the first to examine Hebrew University biomedical breakthroughs. We then capitalize decades of experience – transforming the inventions into pioneering companies.
Our golden eggs
A late stage company with a unique lipid-based cytotoxic agent under review by FDA for marketing authorization.
A Phase III company that develops host-directed therapeutics to control life-threatening infections.
A Phase II company that develops a novel approach for delaying or preventing the progression to Alzheimer’s Disease in patients diagnosed with mild cognitive impairment (MCI).
Tiltan Pharma Ldt.
A Phase II company that develops a novel oral formulation of four drugs for solid cancer therapy.
A Phase Ib company that develops a novel liposomal prodrug of a cytotoxic agent for cancer therapy.
A preclinical company with a unique formulation of the widely used anesthetic agent, Propofol, that provides a solution to the main drawback of the commercial product Diprivan, bacterial contamination.
A preclinical stage company that develops novel liposomal formulations of known drugs for post-surgical pain, inflammation and cancer.
A preclinical company developing novel topical non-invasive formulations of approved drugs to ocular uses, targeting major disease states and clinical needs.
Hil Applied Medical Ltd
A medical device company with breakthrough laser-based technology that reduces the size, complexity and cost of proton accelerators, marking a significant leap in radiation therapy.
The best innovations in Israeli biotech